New universal chimeric antigen receptor T cells specific for CD22

• 收藏
• 分享

专利权人:

Cellectis SA

发明人:

Schiffer-Mannioui, Cecile,Duchateau, Philippe,Gautron, Anne-Sophie

申请号：

AU2018246378

公开号：

AU2018246378A1

申请日:

2018.03.30

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

The present invention relates to new CD22 Chimeric Antigen Receptors (CD22 CAR), an engineered immune cell endowed with said new CD22 CAR and comprising at least inactivated TRAC gene for use in therapy. The engineered immune cells endowed with such CARs are particularly suited for treating relapsed refractory CD22 expressing cancers.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/